Replies to post #195033 on Biotech Values

[DewDiligence]

PTLA selling 2.99M* shares at unspecified price:

http://finance.yahoo.com/news/portola-pharmaceuticals-announces-proposed-offering-213511578.html

Not the best timing, perhaps, but PTLA does need money.

*Assuming exercise of underwriter’s option.

[DewDiligence]

PTLA completes BLA submission for Andexanet Alfa (FXa reversal agent):

http://finance.yahoo.com/news/portola-pharmaceuticals-completes-bla-submission-130000329.html

The name, Annexa A, which PTLA had used in prior investor communications, has apparently been discarded.

Please see #msg-116997511 for background info on the phase-3 and phase-4 program for this drug.